Navigation Links
Leading Cardiologist Dispels the Myths about Dietary Supplement Niacin
Date:12/13/2012

elease system utilized by Slo-Niacin®, is designed to minimize the symptoms of flushing. Slo-Niacin® provides the doctor-recommended form of niacin, nicotinic acid, to help support good cholesterol while reducing the likelihood of flushing.

"I have been recommending dietary supplement niacin in the form of nicotinic acid in my clinic for heart health support for more than two decades," commented Dr. Lavie. "Like many of my colleagues, I recommend Slo-Niacin® because it contains nicotinic acid, the only form of dietary supplement niacin with the clinical support to back its heart health claims. I prefer Slo-Niacin® for my patients because I trust that the nicotinic acid will help to maintain good cholesterol levels and my patients have few issues incorporating Slo-Niacin® into their routine because the unique polygel® controlled-release system is designed to reduce the likelihood of niacin flushing," added Lavie.     

About Flushing

When taking dietary supplement niacin, some people, but not all, may experience a side effect called niacin flushing. Flushing may occur with the use of nicotinic acid, which causes temporary vasodilation or widening of blood vessels in the skin. Slo-Niacin® Tablets utilize a unique polygel® controlled-release system that ensures the gradual and measured release of doctor-recommended nicotinic acid and is designed to minimize flushing associated with niacin use.

About Niacin and Nicotinic Acid

Niacin is a B vitamin that occurs naturally and aids in the function of the digestive system, skin, and nervous system and can help maintain good cholesterol within the normal range. Nicotinic acid, a form of niacin, has been used since the 1950s to support healthy good cholesterol.

About Slo-Niacin®'/>"/>

SOURCE Upsher-Smith Laboratories, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. DenMat Announces Signing a Purchase Agreement to Acquire PeriOptix Inc., Leading Provider of Magnification and Illumination Technologies
2. Drugs.com Releases Q3 Sales for Top 100 U.S. Drugs: Singulair Drops But Nexium and Abilify Remain the Leading Brands
3. World Diagnostic Imaging Market Outlook and Leading Suppliers Business Strategies and Marketing Tactics
4. Validus Pharmaceuticals Now Exclusively Marketing Six Established U.S. Product Lines Purchased From Leading Healthcare Company
5. Optimal Radiology Partners with Leading Radiology Practice
6. Frost & Sullivan Solidifies the Prominence of Leading Organizations through Best Practice Recognition
7. Omeros Responds to Misleading Announcement by Davis Wright Tremaine Concerning Settlement with Former Chief Financial Officer
8. 90 Presentations at Leading Radiation Oncology Meeting Demonstrate the Breadth and Depth of Clinical Evidence for Accuray Technologies
9. LABSCO Implements Leading-Edge Technology to Support Growth and Seize Opportunities in the Clinical Laboratory Market
10. Presentations at Leading Radiation Oncology Meeting Highlight CyberKnife Prostate Outcomes from Patients at More Than 40 Centers
11. Varian Medical Systems Selected by Leading Russian Development Foundations to Take Part in High-Profile Supplier Event
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 Research and ... "Global Multiple Sclerosis Drugs Market 2014-2018" report to ... chronic, inflammatory medical condition that results in demyelination, axonal ... of an abnormal response by the immune system, which ... is a potentially debilitating disease in which the damage ...
(Date:8/29/2014)...  Abaxis, Inc. (NasdaqGS: ABAX ), a ... to the medical, research and veterinary markets, announced today ... Officer, will present at the CL King 12 th ... 9, 2014 at 12:30 p.m. ET. The conference will ... New York City . ...
(Date:8/29/2014)... MENLO PARK, Calif. , Aug. 29, 2014 /PR ... ("DelMar" "the Company") today announced the filing of June ... changed its fiscal year end to June 30th in ... stock on a national securities exchange in the timeliest ... with the United States Securities Exchange Commission can be ...
Breaking Medicine Technology:Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 2Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 3Abaxis, Inc. to Present at CL King's 12th Annual Best Ideas Conference 2014 2DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 2DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 3DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 4DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 5
... April 14, 2011 Oxford Finance Corporation (Oxford), a ... a $2 million equipment loan with Synta Pharmaceuticals Corp. ... compounds for use in Synta,s ongoing clinical trials in ... "Synta Pharmaceuticals has a diverse drug pipeline, including ...
... (NYSE: BT ) shared its vision of ... cloud computing strategies to pharma research at the Bio-IT ... This vision reflects BT,s strong capabilities and increasing specialization ... world,s leading pharmaceutical companies rely on BT to support ...
Cached Medicine Technology:Oxford Finance Corporation Provides a $2 Million Equipment Facility to Synta Pharmaceuticals Corp. 2BT Pushes for R&D Innovation at Bio-IT World Conference 2BT Pushes for R&D Innovation at Bio-IT World Conference 3
(Date:8/29/2014)... yesterday by the Mental Health Commission of Canada ... and education that police personnel receive. , "People ... Canada,s police community, and today,s report builds on ... people with mental illnesses," says Queen,s adjunct professor ... in the area of police psychology. "This is ...
(Date:8/29/2014)... New York, New York (PRWEB) August 29, 2014 ... died from cardiac arrest following a series of dialysis ... that alleges her death was the result of ... Liebhard LLP reports. The family’s lawsuit, which was file ... 2014, claims that the use of the products resulted ...
(Date:8/29/2014)... A team of scientists from the University of Colorado ... a process to expand production of stem cells used ... that extend beyond cancer, including treatments for inborn immunodeficiency ... article published Aug. 29 in PLOS ONE ... Regenerative Medicine and Stem Cell Biology and Taiga Biotechnologies, ...
(Date:8/29/2014)... IL (PRWEB) August 29, 2014 ... poised to begin accepting applications next month for ... are transitioning into accepting marijuana as a legalized ... and dispensaries will be permitted to operate in ... communities will be best suited to handle legal ...
(Date:8/29/2014)... 2014 LiveOps, Inc., the global leader ... announced that LiveOps has been selected as a call ... of Strength Telethon for the third year in a ... awareness to support MDA’s mission to help children and ... fatal muscle disease. This year’s program includes performances by ...
Breaking Medicine News(10 mins):Health News:Report advocates improved police training 2Health News:GranuFlo Lawsuit News: Family Alleges Woman’s Death Following Dialysis Was Caused by GranuFlo and NaturaLyte, Bernstein Liebhard LLP Reports 2Health News:GranuFlo Lawsuit News: Family Alleges Woman’s Death Following Dialysis Was Caused by GranuFlo and NaturaLyte, Bernstein Liebhard LLP Reports 3Health News:GranuFlo Lawsuit News: Family Alleges Woman’s Death Following Dialysis Was Caused by GranuFlo and NaturaLyte, Bernstein Liebhard LLP Reports 4Health News:CU scientists' discovery could lead to new cancer treatment 2Health News:Medical Marijuana Approaches Legalization in Chicago 2Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 2Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 3Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 4
... , , SAN FRANCISCO, Sept. 22 ... will be a key driver of economic growth in the state over ... almost 1 million workers with a collective earning power of more than ... on whether California,s education system will be able to provide enough health ...
... Finding explains why obese children have higher relapse rates, ... Leukemia cells can hide in fat tissue to evade ... are more likely to develop chemotherapy resistance and have ... found that obese children with leukemia are 50 percent ...
... take into account side effects, researchers say , TUESDAY, ... advanced prostate cancer can increase the risk of heart ... be safer than others, new research has found. , ... advanced prostate cancer or prostate cancer that had spread ...
... Role of Innovation in Global Public Health , , ... Galien USA, the equivalent to the Nobel Prize for pharmaceutical research and ... research can improve health care across the U.S. and around the world. ... M.D., founder of Biogen and a member of the Prix Galien USA ...
... 22 The Neuropathy Association has announced two awardees ... , Every year, The Neuropathy Association--the leading ... neuropathies--awards two scientific research grants, each for $80,000 over ... This year,s grant recipients--Dennis Paul, Ph.D. and co-principal investigator, ...
... , Surgeons Urge Prompt Treatment for Growth Plate ... and outdoors, youth athletes stay active year-round in competitive sports, and for many ... American College of Foot and Ankle Surgeons advises that when a child complains ... warning sign of a serious foot problem. , , ...
Cached Medicine News:Health News:Report Finds Significant Job Opportunities for Californians in Allied Health; Questions State's Education Capacity To Train Workers 2Health News:Report Finds Significant Job Opportunities for Californians in Allied Health; Questions State's Education Capacity To Train Workers 3Health News:Leukemia Cells May Hide in Fat Tissue 2Health News:Hormone Therapy for Prostate Cancer Raises Heart Risks 2Health News:Prix Galien USA to Launch a Health Care Dialogue Among World-Leading Innovators in Science, Economics and Biotech 2Health News:Neuropathy Association Research Grants Advance the Understanding of Diabetic Neuropathy and Autoimmune Neuropathies 2Health News:Heel Pain in Youth Athletes: A Warning Sign 2
Futuremeds Astotherm Plus Blood and Fluid Warmers meet American Blood Bank and ECRI standards., ,Astotherm is a durable warmer you can rely on for many years....
... anesthesia solution for the MRI environment , ... ,The Narkomed MRI-2 is the only ... monitor, designed and engineered to perform, without distance ... environments of up to 3.0 Tesla. This feature ...
... Narkomed GS provides high quality ventilation ... The proven technologies of the AV2+ ... the Narkomed GS user-friendly and intuitive. ... quality Narkomed GS is the perfect ...
... facilities where space is a premium Fabius ... delivery technologies with an ergonomic and compact ... of the Draeger Infinity patient monitoring range ... environment that is a sound investment into ...
Medicine Products: